[CLDX] QoQ Quarter Result on 31-Dec-2009 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
12-Mar-2010
Financial Year
2009
Quarter
31-Dec-2009 [#Q4]
Profit Trend
QoQ- -80.42%
YoY- -73.66%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Revenue 2,408 2,951 3,713 4,733 4,030 2,685 3,732 -25.31%
PBT -8,755 -9,191 -6,245 -13,020 -7,174 -8,705 -7,704 8.89%
Tax -248 -190 -6,324 -159 36 -36 -165 31.18%
NP -9,087 -9,525 -6,582 -12,943 -7,174 -8,705 -7,704 11.62%
Tax Rate - - - - - - - -
Total Cost 11,495 12,476 10,295 17,676 11,204 11,390 11,436 0.34%
Ratio Analysis
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
NP Margin -377.37 -322.77 -177.27 -273.46 -178.01 -324.21 -206.45 49.44%
Per Share
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
EPS -4.27 -4.49 -3.11 -6.13 -6.78 -8.25 -7.30 -30.03%
EPS Diluted -4.27 -4.49 -3.11 -6.13 -6.78 -8.25 -7.30 -30.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.